TY - CHAP
T1 - The emergence of EU governance in public health
T2 - The case of blood policy and regulation
AU - Farrell, Anne-Maree
PY - 2005/3/10
Y1 - 2005/3/10
N2 - On 27 January 2003 the Council and the European Parliament formally adopted a new Directive setting standards of quality and safety in relation to blood and blood products1 (the ‘Blood Directive’). Since 1989 a series of laws had been passed at European Union (EU) level concerning the marketing and licensing of ‘medicinal products’ such as fractionated blood products, although this had been done mainly to further the completion of the internal market (Weatherill 1997). The political fallout from HIV contamination of blood supplies in member states was to provide the catalyst for greater EU involvement in blood policy and regulation in the 1990s, culminating in the adoption of the Blood Directive. Unlike earlier EU legislative initiatives in blood-related matters, this Directive establishes a comprehensive EU-wide regulatory framework for the collection, manufacture and supply of blood and blood products for the first time. Member states had until 8 February 2005 in which to implement the terms of the Directive.
AB - On 27 January 2003 the Council and the European Parliament formally adopted a new Directive setting standards of quality and safety in relation to blood and blood products1 (the ‘Blood Directive’). Since 1989 a series of laws had been passed at European Union (EU) level concerning the marketing and licensing of ‘medicinal products’ such as fractionated blood products, although this had been done mainly to further the completion of the internal market (Weatherill 1997). The political fallout from HIV contamination of blood supplies in member states was to provide the catalyst for greater EU involvement in blood policy and regulation in the 1990s, culminating in the adoption of the Blood Directive. Unlike earlier EU legislative initiatives in blood-related matters, this Directive establishes a comprehensive EU-wide regulatory framework for the collection, manufacture and supply of blood and blood products for the first time. Member states had until 8 February 2005 in which to implement the terms of the Directive.
UR - http://www.scopus.com/inward/record.url?scp=84906467611&partnerID=8YFLogxK
UR - https://www.routledge.com/Health-Governance-in-Europe-Issues-Challenges-and-Theories/Steffen/p/book/9780415364522
U2 - 10.4324/9780203015582-13
DO - 10.4324/9780203015582-13
M3 - Chapter
AN - SCOPUS:84906467611
SN - 9780415364522
SN - 9781138975880
T3 - Routledge/ECPR Studies in European Political Science
SP - 134
EP - 151
BT - Health Governance in Europe
A2 - Steffen, Monika
PB - Routledge
CY - London
ER -